Human Interferon Lambda-1 (IFNL1) Protein

Este producto es parte de IFNL1 - interferon lambda 1
Product Graph
312€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Interferon Lambda-1 (IFNL1) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx694121
tested applications
SDS-PAGE

Description

Human Interferon Lambda-1 (IFNL1) Protein is a recombinant Human protein expressed in HEK293 cells.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Host
HEK293 cells
Origin
Human
Observed MW
Molecular Weight: Calculated MW: 22 kDa  Observed MW (SDS-PAGE): 28-35 kDa
Sequence Fragment: Met1-Thr200
Tag: N-terminal 10 His tag
Expression
Recombinant
Purity
>95% (SDS-PAGE)
Size 1
20 µg
Size 2
100 µg
Form
Lyophilized Reconstitute in sterile H2O. Do not vortex.
Tested Applications
SDS-PAGE
Buffer
Prior to lyophilization: PBS, pH 7.4, 5% Trehalose, 5% Mannitol, 0.01% Tween-80.
Availability
Shipped within 5-15 working days.
Storage
Store lyophilized between -20 °C and -80 °C.
Dry Ice
No
UniProt ID
Q8IU54
Gene ID
282618
OMIM
6743
Alias
IL29,IL-29,IFN-lambda-1,Cytokine Zcyto21
Background
Protein IFNL1
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Interferon Lambda 1 (IFNL1), also known as IL-29, is a member of the Type III interferon family, which includes IFNL1, IFNL2 (IL-28A), and IFNL3 (IL-28B), and more recently discovered IFNL4. These cytokines are involved in antiviral immunity and have significant overlap in function with Type I interferons (such as IFN-α and IFN-β), but with distinct cellular targeting. IFNL1 plays a key role in the innate immune response, especially in protecting epithelial barriers, such as those found in the lungs, intestines, and liver, from viral infections. Unlike Type I interferons, which have broad activity across multiple cell types, Type III interferons like IFNL1 act primarily on cells that express the interferon lambda receptor (IFNLR1), which is most commonly found on epithelial cells and some immune cells like dendritic cells. This targeted action is thought to provide a more localized antiviral defense while minimizing the systemic inflammatory responses often seen with Type I interferons.

Related Products

EH0195

Human IL-29 (Interleukin 29) ELISA Kit

Ver Producto
FNab04265

IFNL1 antibody

Ver Producto
P6141

Recombinant Human IL-29

Ver Producto